Close

Form 8-K/A CANNAPHARMARX, INC. For: Feb 15

February 22, 2024 7:55 AM EST
true Corrected Exhibits 0001081938 0001081938 2024-02-15 2024-02-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

 

FORM 8-K/A

(Amendment No. 1)

 

 

 

Current Report

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): February 15, 2024

 

 

 

CannaPharmaRX, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware 333-251016 27-4635140

(State or other jurisdiction of incorporation)

(Commission File Number) (IRS Employer ID No.)

 

Suite 3600, 888-3rd Street SW

Calgary, Alberta, Canada T2P 5C5

(Address of principal executive offices, including zip code)

 

(949) 652-6838

(Registrant’s Telephone Number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Securities registered pursuant to Section 12(g) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, par value $0.0001 per share CPMD OTC Markets

 

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b2 of the Securities Exchange Act of 1934 (§240.12b2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

   

 

 

Explanatory Note

 

As previously reported, on February 12, 2024, we entered into a Supply Agreement with Cantek 2019 Ltd. We described this agreement in our Current Report on Form 8-K filed with the Securities and Exchange Commission (the “SEC”) on February 15, 2024. The information set forth in the Initial 8-K is incorporated herein by reference.

 

However, in Item 9.01 of the Initial 8-K a press release rather than the Supply Agreement was erroneously filed as the exhibit. This Current Report on Form 8-K/A amends the Initial 8-K to include the Supply Agreement as an Exhibit thereto.

 

Item 9.01.Financial Statements and Exhibits.

 

The Supply Agreement is being filed as an exhibit herewith.

 

Exhibit Number

Description
1.1 Supply Agreement between CannaPharmaRX, Inc. and D.N.S. Cantek 2019 Ltd dated February 12, 2024
99.1 Press Release
104 Cover Page Interactive Data File formatted in inline XBRL

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 2 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

 

  CANNAPHARMARX, INC.
   
February 22, 2024 By: /s/ Dean Medwid
 

Name:

Title:

Dean Medwid
CEO

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 3 

 

ATTACHMENTS / EXHIBITS

SUPPLY AGREEMENT

PRESS RELEASE

XBRL SCHEMA FILE

XBRL LABEL FILE

XBRL PRESENTATION FILE

IDEA: R1.htm

IDEA: Financial_Report.xlsx

IDEA: FilingSummary.xml

IDEA: MetaLinks.json

IDEA: canna_8k_htm.xml



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings